An audit of the management of melanoma patients at Glasgow Royal Infirmary 1998-2003.
BACKGROUND
Melanoma is an important cause of morbidity and mortality. Recently published Scottish Intercollegiate Guideline Network (SIGN) guidelines outline standard management for melanoma patients in Scotland.


METHODS
We audited the management of consecutive patients diagnosed with melanoma in Glasgow Royal Infirmary (1998-2003), using the SIGN guidelines as a gold standard.


RESULTS
Of 102 patients, 41% were male and 59% were female. The mean ages of men and women were 58 and 50 years respectively. Fifty five per cent of all patients had a superficial spreading melanoma, and the median Breslow thickness was 0.64 mm. The most commonly affected site was the head and neck (29%). Most patients (87%) were referred by their general practitioner, but only 30% were marked as urgent by the referrer, and accordingly the median time to first appointment varied between 20 days (1998) and 52 days (2001). The most frequently noted suspicious feature was irregular pigmentation. The median time to biopsy was 6 days. Seventy-one per cent of patients had an excision biopsy, and of those who did not, most (71%) had lesions on the head and neck. There was poor recording of surgical margins (13%) and histological margins were used to determine the need for re-excision. The SIGN guidelines for re-excision and sentinel lymph node biopsy were closely followed.


CONCLUSIONS
The SIGN guidelines for melanoma have been adhered to in our department, although time to first appointment exceeded national recommendations.
MacDonald
A
A
Department of Dermatology, Glasgow Royal Infirmary. AlisonMacDonald21@hotmail.com
Berty
C
C
Holmes
S
S
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018572:Disease-Free Survival; D005260:Female; D019983:Guideline Adherence; D006779:Hospitals, Public; D006801:Humans; D008297:Male; D008485:Medical Audit; D008545:Melanoma / Q000401:mortality / Q000628:therapy*; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D012606:Scotland / Q000453:epidemiology; D012878:Skin Neoplasms / Q000401:mortality / Q000628:therapy*; D013997:Time Factors; D016896:Treatment Outcome